General Information of Drug (ID:
DR2809) |
Drug Name |
NSC-14983
|
Synonyms |
Aspartic acid, N-carbamoyl-; Carbamoylaspartic acid; Carbamyl-L-aspartic acid; Carbamylaspartic acid; L-N-Carbamoylaspartic acid; L-Ureidosuccinate; L-Ureidosuccinic acid; N-(aminocarbonyl)-L-aspartic acid; N-Carbamoyl-L-aspartic acid; N-Carbamoyl-S-aspartic acid; N-Carbamoylaspartic acid; N-carbamoyl-L-aspartate; R2521024DK; Succinic acid, ureido-; Ureidosuccinate; carbamyl-aspartate; 13184-27-5; 2-Ureidobutanedioic acid; EINECS 236-134-3; L-Aspartic acid, N-(aminocarbonyl)-; NSC 14983; UNII-R2521024DK
|
Indication |
Dyslipidaemia
[ICD11: 5C81]
|
Phase 1
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
176.13 |
Topological Polar Surface Area |
130 |
Heavy Atom Count |
12 |
Rotatable Bond Count |
4 |
Hydrogen Bond Donor Count |
4 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 93072
- ChEBI ID
-
- CAS Number
-
- Formula
- C5H8N2O5
- Canonical SMILES
- C(C(C(=O)O)NC(=O)N)C(=O)O
- InChI
- 1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/t2-/m0/s1
- InChIKey
- HLKXYZVTANABHZ-REOHCLBHSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.